sellWeak
Larry Michael Mertz sold $318 of AXDX
Chief Technology Officer at Accelerate Diagnostics, Inc. 361 shares at an average of $0.88, traded May 20, 2024, filed May 21, 2024.
Warning score
0Value
$318
361 shares
Holdings after
82,028
-0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$318 at market
- 0Share of holdings soldSold 0.4% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-24-063967, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 20, 2024 | MOption exercise Common Stock | +1,000 | $0.00 | $0 | 82,106 | May 21, 2024 |
| May 20, 2024 | SOpen-market sale Common Stock | -275 | $0.88 | $242 | 81,831 | May 21, 2024 |
| May 20, 2024 | MOption exercise Common Stock | +283 | $0.00 | $0 | 82,114 | May 21, 2024 |
| May 20, 2024 | SOpen-market sale Common Stock | -86 | $0.88 | $76 | 82,028 | May 21, 2024 |
| May 20, 2024 | MOption exercise Employee Restricted Stock Unitsderivative | -1,000 | $0.00 | $0 | 0 | May 21, 2024 |
| May 20, 2024 | MOption exercise Employee Restricted Stock Unitsderivative | -283 | $0.00 | $0 | 0 | May 21, 2024 |
Related signals
Other insiders at Accelerate Diagnostics, Inc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | Accelerate Diagnostics, Inc | Larry Michael Mertz Chief Technology Officer | $990 1,523 shares | -2% | |
| 30Weak | Accelerate Diagnostics, Inc | Jack Phillips Chief Executive Officer | $16k 25,343 shares | -12% | |
| 22Weak | Accelerate Diagnostics, Inc | David Patience Chief Financial Officer | $4,839 6,816 shares | -10% | |
| 7Weak | AXDXsell Accelerate Diagnostics, Inc | David Patience Chief Financial Officer | $583 535 shares | -1% | |
| 10Weak | AXDXsell Accelerate Diagnostics, Inc | Jack Phillips Chief Executive Officer | $655 485 shares | -0% | |
| 29Weak | AXDXsell Accelerate Diagnostics, Inc | Jack W Schuler director, owner | $314k 200,000 shares | -2% | |
| 35Weak | AXDXbuy Accelerate Diagnostics, Inc | John Patience director | $314k 200,000 shares | +44% | |
| 10Weak | Accelerate Diagnostics, Inc | Jack Phillips Chief Executive Officer | $21k 26,735 shares | -14% | |
| 10Weak | Accelerate Diagnostics, Inc | Jack Phillips Chief Executive Officer | $23k 26,545 shares | -17% | |
| 20Weak | Accelerate Diagnostics, Inc | Larry Michael Mertz Chief Technology Officer | $12k 13,984 shares | -15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.